SOPs for Nanoparticle Formulation

This SOP outlines the procedure for optimizing particle size in nanoparticle formulations. Particle size is a critical factor influencing drug release, stability, and bioavailability, and must be optimized to meet the therapeutic objectives of the formulation.
Click to read the full article.

This SOP outlines the procedure for preparing nanoparticles intended for gene delivery. Nanoparticles are used to deliver nucleic acids (e.g., DNA, RNA) to cells, protecting the genetic material and enhancing cellular uptake for gene therapy applications.
Click to read the full article.

This SOP outlines the procedure for incorporating peptides into nanoparticle formulations for targeted delivery or therapeutic applications. Peptides can be used as therapeutic agents or as targeting ligands to enhance the specificity of nanoparticles.
Click to read the full article.

This SOP outlines the procedure for formulating protein-based nanoparticles, which are used for the delivery of peptides, proteins, or therapeutic agents. Protein-based nanoparticles are biocompatible, biodegradable, and suitable for targeted drug delivery.
Click to read the full article.

This SOP outlines the procedure for preparing nanoparticles intended for ocular delivery. These nanoparticles are designed to deliver therapeutic agents directly to the eye, targeting the anterior or posterior segments of the eye for sustained release and improved bioavailability.
Click to read the full article.

This SOP outlines the procedure for incorporating targeting ligands, such as antibodies or peptides, into nanoparticle formulations to improve the specificity and efficacy of drug delivery by targeting diseased cells or tissues.
Click to read the full article.

This SOP outlines the procedure for preparing nanoparticles intended for nasal delivery. Nasal delivery provides a non-invasive route for administering drugs directly to the systemic circulation or central nervous system via the nasal cavity.
Click to read the full article.

This SOP outlines the procedure for formulating nanoparticles designed for cancer therapy. These nanoparticles are used to deliver chemotherapeutic agents directly to cancer cells, improving efficacy and reducing systemic side effects.
Click to read the full article.

This SOP outlines the procedure for preparing carbon-based nanomaterials, such as graphene, carbon nanotubes, and fullerenes, which are used in various applications including drug delivery, electronics, and energy storage.
Click to read the full article.

This SOP outlines the procedure for preparing nanoparticles specifically designed for transdermal drug delivery. Transdermal delivery systems aim to deliver therapeutic agents through the skin, providing a controlled and sustained release.
Click to read the full article.